Daily Values

Growth Metrics

Income Statement

Asset Management Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Equity Income Financial Services Fees Gross Profit Income from Continuing Operations Income from Non-Controlling Interests Income towards Parent Company Interest & Investment Income Interest Expense - Debt Interest Expense - Fed Funds Interest Expenses Interest Income - Net Interest Income - Total Interest Income - Trading Account Assets Interest income - Loans Investment Gain (Loss)Net Income - Minority Net Income towards Common Stockholders Non Operating Income Non-Interest Income Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Principal Transactions Profit After Tax Provisions Research & Development Revenue Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions Tax Rate Trading Income Wages, Salaries and Other

Others

Cohen (COHN) Research & Development (2024 - 2025)

Cohen (COHN) has disclosed Research & Development for 2 consecutive years, with $869000.0 as the latest value for Q3 2025.

For the quarter ending Q3 2025, Research & Development rose 86.08% year-over-year to $869000.0, compared with a TTM value of $2.7 million through Sep 2025, changed N/A, and an annual FY2024 reading of $2.3 million, up 61.27% over the prior year.
Research & Development was $869000.0 for Q3 2025 at Cohen, up from $814000.0 in the prior quarter.
Across five years, Research & Development topped out at $869000.0 in Q3 2025 and bottomed at $456000.0 in Q1 2024.